ReviewThe Annals of pharmacotherapy2019

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease.

Roy A PleasantsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.